Predictors of survival in a series of clinically diagnosed progressive supranuclear palsy patients

Parkinsonism and Related Disorders

Volumn 19, Issue 11, 2013, Pages 980-985

  Dell'Aquila, Claudia ^a   Zoccolella, Stefano ^a   Cardinali, Valentina ^a   De Mari, Michele ^a   Iliceto, Giovanni ^a   Tartaglione, Bruno ^a   Lamberti, Paolo ^a   Logroscino, Giancarlo ^a  

^a UNIVERSITY OF BARI   (Italy)

Author keywords

Natural history; Parkinsonism; Progressive supranuclear gaze palsy; Steele Richardson Olszewski syndrome; Survival

Indexed keywords

DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA;

ADULT; ARTICLE; CAREGIVER; CLINICAL ARTICLE; COGNITIVE DEFECT; DEMENTIA; DISEASE SEVERITY; DYSPHAGIA; FEMALE; FOLLOW UP; HUMAN; INSTITUTIONALIZATION; MALE; MEDICAL HISTORY; MORTALITY; MOTOR DYSFUNCTION; ONSET AGE; PARKINSONISM; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; RETROSPECTIVE STUDY; SPEECH DISORDER; SURVIVAL RATE; TELEPHONE INTERVIEW; WALKING DIFFICULTY;

NATURAL HISTORY; PARKINSONISM; PROGRESSIVE SUPRANUCLEAR GAZE PALSY; STEELE-RICHARDSON-OLSZEWSKI SYNDROME; SURVIVAL;

AGED; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; SUPRANUCLEAR PALSY, PROGRESSIVE; SURVIVAL RATE;

EID: 84886588212     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2013.06.014     Document Type: Article

References (26)

1. Steele J.C., Richardson J.C., Olszewski J. Progressive supranuclear palsy. A heterogeneous degeneration involving the brain stem, basal ganglia and cerebellum with vertical gaze and pseudobulbar palsy, nuchal dystonia and dementia. Arch Neurol 1964, 10:333-359.
2. Nath U., Ben-Shlomo Y., Thomson R.G., Lees A.J., Burnet D.J. The prevalence of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) in the UK. Brain 2001, 24:1438-1449.
3. Williams D.R., de Silva R., Paviour D.C., Pittman A., Watt H.C., Kilford L., et al. Characteristics of two clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-Parkinsonism. Brain 2005, 128:1247-1258.
4. Williams D.R., Holton J.L., Strand K., Revesz T., Lees A.J. Pure akinesia with gait freezing: a third clinical phenotype of progressive supranuclear palsy. Mov Disord 2007, 22:2235-2241.
5. Donker Kaat L., Boon A.J.W., Kamphorst W., Ravid R., Duivenvoorden H.J., van Swietenet J.C. Frontal presentation in progressive supranuclear palsy. Neurology 2007, 69:723-729.
6. Golbe L.I., Davis P.H., Schoenberg B.S., Duvoisin R.C. Prevalence and natural history of progressive supranuclear palsy. Neurology 1988, 38:1031-1034.
7. Litvan I., Mangone C.A., McKee A., Veiny M., Parsa A., Jellinger K., et al. Natural history of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) and clinical predictors of survival: a clinicopathological study. JNeurol Neurosurg Psychiatr 1996, 61:615-620.
8. Nath U., Ben-Shlomo Y., Thomson R.G., Lees A.J., Burn D.J. Clinical features and natural history of progressive supranuclear palsy. A clinical cohort study. Neurology 2003, 60:910-916.
9. Papapetropoulos S., Gonzalez J., Mash D.C. Natural history of progressive supranuclear palsy: a clinicopathological study from a population of brain donors. Eur Neurol 2005, 54:1-9.
10. Golbe L.I., Ohman-Strickland P.A. Aclinical rating scale for progressive supranuclear palsy. Brain 2007, 130:1552-1565.
11. O'Sullivan S.S., Massey L.A., Williams D.R., Silveira-Moriyama L., Kempster P.A., Holton J.L., et al. Clinical outcomes of progressive supranuclear palsy and multiple system atrophy. Brain 2008, 131:1362-1372.
12. Lang A.E. Treatment of progressive supranuclear palsy and corticobasal degeneration. Mov Disord 2005, 20(Suppl.12):S83-S91.
13. Stamelou M., Reuss A., Pilatus U., Magerkurth J., Niklowitz P., Eggert K.M., et al. Short term effects of coenzyme Q10 in progressive supranuclear palsy: a randomize, placebo-controlled trial. Mov Disord 2008, 23:942-949.
14. Bensimon G., Ludolph A., Agid Y., Vidailhet M., Payan C., Nigel Leigh P., NNIPPS Study Group Riluzole treatment, survival and diagnostic criteria in Parkinson plus disorders: the NNIPPS study. Brain 2009, 132:156-171.
15. Litvan I., Agid Y., Calne D., Campbell G., Dubois B., Duvoisin R.C., et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology 1996, 47:1-9.
16. American psychiatric association diagnostic and statistical manual of mental disorders DSM-IV-TR fourth edition 2000, American Psychiatric Association, Washington, DC.
17. Maher E.R., Lees A.J. The clinical features and natural history of the Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). Neurology 1986, 36:1005-1008.
18. Santacruz P., Uttl B., Litvan I., Grafman J. Progressive supranuclear palsy: a survey of the disease course. Neurology 1998, 50:1637-1647.
19. Testa D., Monza D., Ferrarini M., Soliveri P., Girotti F., Filippini G. Comparison of natural histories of progressive supranuclear palsy and multiple system atrophy. Neurol Sci 2001, 22:247-251.
20. Diroma C., Dell'Aquila C., Fraddosio A., Lamberti S., Mastronardi R., Russo I., et al. Natural history and clinical features of progressive supranuclear palsy: a clinical study. Neurol Sci 2003, 24:176-177.
21. Goetz C.G., Leurgans S., Lang A.E., Litvan I. Progression of gait, speech and swallowing deficits in progressive supranuclear palsy. Neurology 2003, 60:917-922.
22. Chiu W.Z., Kaat L.D., Seelaar H., Rosso S.M., Boon A.J.W., Kamphorst W., et al. Survival in progressive supranuclear palsy and frontotemporal dementia. JNeurol Neurosurg Psychiatr 2010, 81:441-445.
23. Daniel S.E., de Bruin V.M., Lees A.J. The clinical and pathological spectrum of Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy): a reappraisal. Brain 1995, 118:759-770.
24. Litvan I., Agid Y., Jankovic J., Goetz C., Brandel J.P., Lai E.C., et al. Accuracy of clinical criteria for the diagnosis of progressive supranuclear palsy(Steele-Richardson-Olszewski syndrome). Neurology 1996, 46:922-930.
25. Hughes A.J., Daniel S.E., Ben-Shlomo Y., Lees A.J. The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service. Brain 2002, 125:861-870.
26. Maraganore D.M., Anderson D.W., Bower J.H., McDonnell S.K., Rocca W.A. Autopsy patterns for Parkinson's disease and related disorders in Olmsted County, Minnesota. Neurology 1999, 53:1342-1344.